Oral 5‐ASA vs 5‐aminosalicylic acid (5‐ASA) (mesalazine)
Failure to induce global or clinical improvement · Patients with active mild to moderate ulcerative colitis
Oral 5‐ASA showed no clear difference in failure to induce global or clinical improvement compared with comparator 5‐ASA (moderate certainty).
1 finding from 1 review
- Oral 5‐aminosalicylic acid for induction of remission in ulcerative colitis 2020 · Cochrane Headline outcomes onlyRR 0.89 [0.77, 1.01]8 studies · 1647 participantsModerate